<p><strong>独家报道：</strong> 据 FOX Business 了解，白宫预计将宣布扩大在 TrumpRx.gov 上提供折扣的制药公司名单。</p>
<p>最早在今天，安进和葛兰素史克将被加入到在政府网站上提供折扣的处方药制造商名单中。这使得在特朗普总统的压力和关税威胁下，已有六家制药公司签署了最惠国定价协议，共计 54 种处方药。</p>
<p>安进将在网站上提供一种药物，零售价降低 80%。Amjevita 的原价为 1484 美元，但在 TrumpRx.gov 上售价为 299 美元。这种药物用于治疗类风湿关节炎、银屑病和溃疡性结肠炎。</p>
<p><strong>福克斯新闻民调：选民对医疗成本发出警报</strong></p>
<p><img src="https://imageproxy.pbkrs.com/https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2026/03/931/523/trump-dr-oz-trumprx.jpg/query-dGw9MSZ2ZT0x?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="931" height="523" original-src="https://imageproxy.pbkrs.com/https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2026/03/931/523/trump-dr-oz-trumprx.jpg/query-dGw9MSZ2ZT0x"/></p>
<p>特朗普总统在 2026 年 2 月 5 日于华盛顿特区白宫校园南法院礼堂举行的药品定价活动上发言，医疗保险和医疗补助服务中心的管理员 Mehmet Oz 在旁观看。（Nathan Howard/Getty Images）</p>
<p>该公司计划将 Aimovig 和 Repatha 的折扣定为 62%。</p>
<p>葛兰素史克将 Incruse 的折扣定为零售价的 55%。该药物用于治疗慢性阻塞性肺病，售价为 159 美元。</p>
<p>葛兰素史克还计划将 Arnuity、Relenza 和 Anoro 的折扣范围定为 10% 至 51%。</p>
<table>
<thead>
<tr>
<th>股票代码</th>
<th>证券</th>
<th>最新</th>
<th>变动</th>
<th>变动 %</th>
</tr>
</thead>
<tbody>
<tr>
<td>AMGN</td>
<td>安进</td>
<td>366.21</td>
<td>-1.58</td>
<td>-0.43%</td>
</tr>
<tr>
<td>GSK</td>
<td>葛兰素史克</td>
<td>53.39</td>
<td>-0.89</td>
<td>-1.64%</td>
</tr>
<tr>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
</tbody>
</table>
<p>白宫发言人 Kush Desai 对 FOX Business 表示：&#34;葛兰素史克和安进通过 TrumpRx.gov 直接向消费者提供处方药，以最惠国定价的方式，标志着特朗普总统在推动药品可负担性方面又一个里程碑。&#34;</p>
<p>&#34;然而，TrumpRx.gov 仅仅是个开始，随着国会通过特朗普总统的伟大医疗计划，美国人将获得更大的药品价格折扣、更低的保险费和更多的透明度。&#34;</p>
<p><img src="https://imageproxy.pbkrs.com/https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2025/12/931/523/pharmacy-tech.png/query-dGw9MSZ2ZT0x?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="931" height="523" original-src="https://imageproxy.pbkrs.com/https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2025/12/931/523/pharmacy-tech.png/query-dGw9MSZ2ZT0x"/></p>
<p>安进将在网站上提供一种药物，零售价降低 80%。(George Frey/Bloomberg via Getty Images)</p>
<p>美国制药研究与制造商协会代表主要制药公司。</p>
<p>首席执行官 Stephen Ubl 认为：&#34;政府强加的最惠国政策将削弱美国的竞争力，同时对解决拒绝医疗和提高患者成本的保险做法毫无帮助。&#34;</p>
<p><strong>众议院共和党寻求解决数百万美国人高昂医疗保险成本的出路</strong></p>
<p>&#34;这些政策将从美国的研发中抽走数十亿美元，减缓治愈的进程，并增加对中国未来创新的依赖。&#34;</p>
<p><img src="https://imageproxy.pbkrs.com/https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2024/04/931/523/Pharmacy-drugs-Walgreens.jpg/query-dGw9MSZ2ZT0x?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="931" height="523" original-src="https://imageproxy.pbkrs.com/https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2024/04/931/523/Pharmacy-drugs-Walgreens.jpg/query-dGw9MSZ2ZT0x"/></p>
<p>葛兰素史克将 Incruse 的折扣定为零售价的 55%。(Jeffrey Greenberg/Universal Images Group via Getty Images)</p>
<p>白宫正在推进对 TrumpRx.gov 的公告，因为美国人正在寻找降低医疗成本的方法。</p>
<p><strong>点击这里获取福克斯商业新闻移动版</strong></p>
<p>根据拜登政府的数据显示，劳工统计局的数据表明，从 2021 年 1 月到 2025 年 1 月，处方药成本增加了 10.4%。而在特朗普政府期间，从 2025 年 1 月到 2026 年 2 月的最新数据，处方药价格仅增加了 0.2%。</p>

动态生物技术与基因组 ETF - Invesco

IBBQ

标普生物技术 ETF - SPDR

<p>白宫即将宣布在 TrumpRx.gov 上扩大药品折扣，安进和葛兰素史克将加入这一倡议。这将使得在最惠国定价下，六家公司提供的药物总数增加到 54 种。安进将提供高达 80% 的折扣，而葛兰素史克将提供高达 55% 的折扣。该倡议旨在降低美国人的医疗成本，与拜登政府下药品价格上涨形成对比。批评者认为，这类政策可能会损害美国在药物开发方面的竞争力和创新能力</p>

<p><strong>EXCLUSIVE:</strong> The White House is expecting to announce an expansion of drugmakers offering discounts on TrumpRx.gov, FOX Business has learned.</p>
<div class="lb-trans"><p><strong>独家报道：</strong> 据 FOX Business 了解，白宫预计将宣布扩大在 TrumpRx.gov 上提供折扣的制药公司名单。</p>
</div><p>As early as today, Amgen and GSK will be added to the list of prescription drug manufacturers offering discounts on the government website. That makes a total of 54 prescription medications from six pharmaceutical companies that have signed on to the most-favored-nation pricing under pressure from President Donald Trump and the threat of tariffs.</p>
<div class="lb-trans"><p>最早在今天，安进和葛兰素史克将被加入到在政府网站上提供折扣的处方药制造商名单中。这使得在特朗普总统的压力和关税威胁下，已有六家制药公司签署了最惠国定价协议，共计 54 种处方药。</p>
</div><p>Amgen will offer medication on the website that cuts 80% off the retail price. Amjevita has an original price of $1,484, but will be available on TrumpRx.gov for $299. The medication treats rheumatoid arthritis, psoriasis and ulcerative colitis.</p>
<div class="lb-trans"><p>安进将在网站上提供一种药物，零售价降低 80%。Amjevita 的原价为 1484 美元，但在 TrumpRx.gov 上售价为 299 美元。这种药物用于治疗类风湿关节炎、银屑病和溃疡性结肠炎。</p>
</div><p><strong>FOX NEWS POLL: VOTERS SOUND ALARM ON HEALTHCARE COSTS</strong></p>
<div class="lb-trans"><p><strong>福克斯新闻民调：选民对医疗成本发出警报</strong></p>
</div><p><img src="https://imageproxy.pbkrs.com/https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2026/03/931/523/trump-dr-oz-trumprx.jpg/query-dGw9MSZ2ZT0x" alt="" original-src="https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2026/03/931/523/trump-dr-oz-trumprx.jpg?ve=1&amp;tl=1"/></p>
<p>President Donald Trump speaks as Administrator for the Centers for Medicare &amp; Medicaid Services Mehmet Oz looks on during an event on drug pricing in the South Court Auditorium on the White House campus Feb. 5, 2026, in Washington, D.C. (Nathan Howard/Getty Images)</p>
<div class="lb-trans"><p>特朗普总统在 2026 年 2 月 5 日于华盛顿特区白宫校园南法院礼堂举行的药品定价活动上发言，医疗保险和医疗补助服务中心的管理员 Mehmet Oz 在旁观看。（Nathan Howard/Getty Images）</p>
</div><p>The company plans to list Aimovig and Repatha for discounts of 62%.</p>
<div class="lb-trans"><p>该公司计划将 Aimovig 和 Repatha 的折扣定为 62%。</p>
</div><p>GSK will discount Incruse at 55% of the retail price. The drug treats COPD and will be listed at $159.</p>
<div class="lb-trans"><p>葛兰素史克将 Incruse 的折扣定为零售价的 55%。该药物用于治疗慢性阻塞性肺病，售价为 159 美元。</p>
</div><p>GSK also plans to list Arnuity, Relenza and Anoro at discounts ranging from 10% to 51%.</p>
<div class="lb-trans"><p>葛兰素史克还计划将 Arnuity、Relenza 和 Anoro 的折扣范围定为 10% 至 51%。</p>
</div><table>
<thead>
<tr>
<th>Ticker</th>
<th>Security</th>
<th>Last</th>
<th>Change</th>
<th>Change %</th>
</tr>
</thead>
<tbody>
<tr>
<td>AMGN</td>
<td>AMGEN INC.</td>
<td>366.21</td>
<td>-1.58</td>
<td>-0.43%</td>
</tr>
<tr>
<td>GSK</td>
<td>GSK PLC</td>
<td>53.39</td>
<td>-0.89</td>
<td>-1.64%</td>
</tr>
<tr>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th>股票代码</th>
<th>证券</th>
<th>最新</th>
<th>变动</th>
<th>变动 %</th>
</tr>
</thead>
<tbody>
<tr>
<td>AMGN</td>
<td>安进</td>
<td>366.21</td>
<td>-1.58</td>
<td>-0.43%</td>
</tr>
<tr>
<td>GSK</td>
<td>葛兰素史克</td>
<td>53.39</td>
<td>-0.89</td>
<td>-1.64%</td>
</tr>
<tr>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
</tbody>
</table>
</div><p>&#34;GSK and Amgen connecting with TrumpRx.gov to offer prescription drugs directly to consumers at most-favored-nations pricing marks another milestone for President Trump’s affordability push,&#34; White House spokesman Kush Desai told FOX Business.</p>
<div class="lb-trans"><p>白宫发言人 Kush Desai 对 FOX Business 表示：&#34;葛兰素史克和安进通过 TrumpRx.gov 直接向消费者提供处方药，以最惠国定价的方式，标志着特朗普总统在推动药品可负担性方面又一个里程碑。&#34;</p>
</div><p>&#34;TrumpRx.gov is just the beginning, however, as Americans are set to (receive) even greater drug pricing discounts, lower insurance premiums and more transparency when Congress passes President Trump’s Great Healthcare Plan.&#34;</p>
<div class="lb-trans"><p>&#34;然而，TrumpRx.gov 仅仅是个开始，随着国会通过特朗普总统的伟大医疗计划，美国人将获得更大的药品价格折扣、更低的保险费和更多的透明度。&#34;</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2025/12/931/523/pharmacy-tech.png/query-dGw9MSZ2ZT0x" alt="" original-src="https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2025/12/931/523/pharmacy-tech.png?ve=1&amp;tl=1"/></p>
<p>Amgen will offer medication on the website that cuts 80% off the retail price. (George Frey/Bloomberg via Getty Images)</p>
<div class="lb-trans"><p>安进将在网站上提供一种药物，零售价降低 80%。(George Frey/Bloomberg via Getty Images)</p>
</div><p>The Pharmaceutical Research and Manufacturers of America represents major drug companies.</p>
<div class="lb-trans"><p>美国制药研究与制造商协会代表主要制药公司。</p>
</div><p>CEO Stephen Ubl believes &#34;Government-imposed most-favored-nation policies would undermine U.S. competitiveness while doing nothing to address insurance practices that deny care and raise costs for patients.</p>
<div class="lb-trans"><p>首席执行官 Stephen Ubl 认为：&#34;政府强加的最惠国政策将削弱美国的竞争力，同时对解决拒绝医疗和提高患者成本的保险做法毫无帮助。&#34;</p>
</div><p><strong>HOUSE GOP SEEKS OFF-RAMP TO SKY-HIGH HEALTH INSURANCE COSTS FOR MILLIONS OF AMERICANS</strong></p>
<div class="lb-trans"><p><strong>众议院共和党寻求解决数百万美国人高昂医疗保险成本的出路</strong></p>
</div><p>&#34;These policies would siphon billions from American R&amp;D, slow the pace of cures and increase reliance on China for future innovation.&#34;</p>
<div class="lb-trans"><p>&#34;这些政策将从美国的研发中抽走数十亿美元，减缓治愈的进程，并增加对中国未来创新的依赖。&#34;</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2024/04/931/523/Pharmacy-drugs-Walgreens.jpg/query-dGw9MSZ2ZT0x" alt="" original-src="https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2024/04/931/523/Pharmacy-drugs-Walgreens.jpg?ve=1&amp;tl=1"/></p>
<p>GSK will discount Incruse at 55% of the retail price. (Jeffrey Greenberg/Universal Images Group via Getty Images)</p>
<div class="lb-trans"><p>葛兰素史克将 Incruse 的折扣定为零售价的 55%。(Jeffrey Greenberg/Universal Images Group via Getty Images)</p>
</div><p>The White House is pushing ahead with announcements to TrumpRx.gov as Americans look for ways to cut medical costs.</p>
<div class="lb-trans"><p>白宫正在推进对 TrumpRx.gov 的公告，因为美国人正在寻找降低医疗成本的方法。</p>
</div><p><strong>GET FOX BUSINESS ON THE GO BY CLICKING HERE</strong></p>
<div class="lb-trans"><p><strong>点击这里获取福克斯商业新闻移动版</strong></p>
</div><p>Under the Biden administration, Bureau of Labor Statistics data shows, prescription drug costs increased 10.4% from January 2021 to January 2025. Under the Trump administration, prescription drug prices increased 0.2% from January 2025 through the latest data from February 2026.</p>
<div class="lb-trans"><p>根据拜登政府的数据显示，劳工统计局的数据表明，从 2021 年 1 月到 2025 年 1 月，处方药成本增加了 10.4%。而在特朗普政府期间，从 2025 年 1 月到 2026 年 2 月的最新数据，处方药价格仅增加了 0.2%。</p>
</div>

特朗普扩大药品折扣计划，两家制药巨头加入 TrumpRx